Camber Capital Management LP 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 08:34 am Sale | 2024-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 0 0.000% | -2,805,000 (Position Closed) | Filing |
| 2024-02-14 08:19 am Sale | 2023-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,805,000 5.900% | -1,430,000 (-33.77%) | Filing |
| 2023-02-14 08:30 am Purchase | 2022-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 4,235,000 9.280% | 1,680,000 (+65.75%) | Filing |
| 2021-02-16 08:21 am Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,555,000 6.430% | 155,000 (+6.46%) | Filing |
| 2020-06-29 6:03 pm Purchase | 2020-06-18 | 13G | Puma Biotechnology, Inc. PBYI | Camber Capital Management LP | 2,400,000 6.100% | 2,400,000 (New Position) | Filing |